What Happened to Theranos? ⚠️ Scandal

Theranos was a U.S. blood-testing startup that claimed it could run hundreds of lab tests from a finger-prick of blood. Founded in 2003 by Elizabeth Holmes, the company pitched a compact analyzer for decentralized diagnostics and pursued retail pilots to place collection sites inside pharmacies. By the mid-2010s, Theranos had become a high-profile Silicon Valley brand with prominent investors, luminaries on its board, and extensive media coverage.

Behind the scenes, Theranos relied largely on modified third-party analyzers while its proprietary devices struggled with accuracy and reliability. In October 2015, a series of investigative reports questioned the company’s technology and quality controls. U.S. regulators subsequently inspected Theranos’s labs, citing serious deficiencies, and retail partnerships paused or wound down as scrutiny intensified.

In 2016, federal regulators banned Holmes from operating a clinical lab and moved to revoke the company’s CLIA certificate. The SEC charged Theranos and its executives in March 2018 with raising money through exaggerated and false statements. By September 2018, Theranos ceased operations and was dissolved. Later criminal proceedings resulted in convictions of the CEO and the former president. The collapse became a landmark case in medical-device governance, underscoring the need for rigorous validation, transparent performance data, and strong clinical oversight.